DE69020755D1 - Physiologisch aktives Polypeptid und DNA. - Google Patents

Physiologisch aktives Polypeptid und DNA.

Info

Publication number
DE69020755D1
DE69020755D1 DE69020755T DE69020755T DE69020755D1 DE 69020755 D1 DE69020755 D1 DE 69020755D1 DE 69020755 T DE69020755 T DE 69020755T DE 69020755 T DE69020755 T DE 69020755T DE 69020755 D1 DE69020755 D1 DE 69020755D1
Authority
DE
Germany
Prior art keywords
edema
activity
physiologically active
polypeptide
active polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69020755T
Other languages
English (en)
Other versions
DE69020755T3 (de
DE69020755T2 (de
Inventor
Tetsuji Sudoh
Keiji Maekawa
Naoto Minamino
Kenji Kangawa
Hisayuki Matsuo
Atsushi Izumi
Mika Takashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
DAIICHI PURE CHEMICALS Co Ltd TOKIO/TOKYO JP
Daiichi Pure Chemicals Co Ltd
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26390052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69020755(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP04963689A external-priority patent/JP3160276B2/ja
Priority claimed from JP1059183A external-priority patent/JP2883903B2/ja
Application filed by DAIICHI PURE CHEMICALS Co Ltd TOKIO/TOKYO JP, Daiichi Pure Chemicals Co Ltd, Daiichi Pharmaceutical Co Ltd filed Critical DAIICHI PURE CHEMICALS Co Ltd TOKIO/TOKYO JP
Publication of DE69020755D1 publication Critical patent/DE69020755D1/de
Application granted granted Critical
Publication of DE69020755T2 publication Critical patent/DE69020755T2/de
Publication of DE69020755T3 publication Critical patent/DE69020755T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69020755T 1989-03-01 1990-03-01 Physiologisch aktives Polypeptid und DNA. Expired - Lifetime DE69020755T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP04963689A JP3160276B2 (ja) 1989-03-01 1989-03-01 新規ｃＤＮＡフラグメント
JP1059183A JP2883903B2 (ja) 1989-03-10 1989-03-10 新規生理活性ペプチド及びその用途

Publications (3)

Publication Number Publication Date
DE69020755D1 true DE69020755D1 (de) 1995-08-17
DE69020755T2 DE69020755T2 (de) 1996-04-04
DE69020755T3 DE69020755T3 (de) 2000-03-02

Family

ID=26390052

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69020755T Expired - Lifetime DE69020755T3 (de) 1989-03-01 1990-03-01 Physiologisch aktives Polypeptid und DNA.

Country Status (6)

Country Link
EP (1) EP0385476B2 (de)
AT (1) ATE124994T1 (de)
CL (1) CL2004001266A1 (de)
DE (1) DE69020755T3 (de)
DK (1) DK0385476T4 (de)
ES (1) ES2076981T5 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6028055A (en) * 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
WO2000018422A1 (fr) * 1998-09-28 2000-04-06 Santen Pharmaceutical Co., Ltd. Promoteurs de secretion lacrymale ou gouttes ophtalmologiques contenant des peptides natriuretiques comme principes actifs pour traiter la keratoconjonctivite
AU2003297583B2 (en) 2002-11-26 2010-01-14 Biocon, Ltd Modified naturetic compounds, conjugates, and uses thereof
US7795221B2 (en) 2006-03-30 2010-09-14 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
WO2007115175A2 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
RU2010114017A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Терапевтическое применение натрийуретического пептида в-типа и гормона роста человека 1-43
PL409596A1 (pl) * 2014-09-25 2016-03-29 Uniwersytet Wrocławski Pochodne pseudofaktyny, sposób otrzymywania pochodnych pseudofaktyny oraz ich zastosowanie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
EP0385476A1 (de) 1990-09-05
ES2076981T3 (es) 1995-11-16
EP0385476B2 (de) 1999-09-22
ES2076981T5 (es) 2000-02-01
EP0385476B1 (de) 1995-07-12
ATE124994T1 (de) 1995-07-15
CL2004001266A1 (es) 2005-02-04
DE69020755T3 (de) 2000-03-02
DK0385476T4 (da) 1999-12-20
DK0385476T3 (da) 1995-10-02
DE69020755T2 (de) 1996-04-04

Similar Documents

Publication Publication Date Title
ATE124994T1 (de) Physiologisch aktives polypeptid und dna.
DK163683A (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykke dna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
DE3786767D1 (de) Neues polypeptid.
ATE183232T1 (de) Herstellung von biologisch aktiven rekombinanten mitgliedern der ngf/bdnf-familie neurotroper proteine
FR2613596B1 (fr) Structure de support de pied, a lanieres en echarpe fixees a la semelle externe d'une chaussure
ATE358176T1 (de) Menschliche dnase
DE3582183D1 (de) Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
DE3882593D1 (de) Polypeptid und dessen herstellung.
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
DK215287A (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
IS6072A (is) Æðasamloðunar sameindir og mótun á starfsemi þeirra
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
ATE132900T1 (de) Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität
AR243237A1 (es) Un vector de expresion recombinante que contiene una secuencia de adn que codifica el factor neurotrofico ciliar humano,un microorganismo e.coli transformado,y linea celulares transformadas.
DE69116704D1 (de) Gen, das ein Polypeptid mit Nitrilhydratase-Aktivität codiert, eine dieses Gen enthaltende Transformante und Verfahren zur Herstellung von Amiden mit dieser Transformante.
DE3782549D1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
DE68918519D1 (de) DNA, welche für ein antikoagulierendes Polypeptid kodiert.
DE69530600D1 (de) Verwendung von nk1-rezeptor antagonisten zur zubereitung von arzneimitteln mit kardioregulierender wirkung
IT8821003A0 (it) Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/ 4 (idrossidifenilmetil) 1piperidinbutanolo".
Burnyasheva et al. On the question of the treatment of urticaria
DK164283C (da) Polypeptid med cystatin c aktivitet, dna-sekvens til udtrykkelse af 3-des-oh-cystatin c eller en modifikation deraf, fremgangsmaade til fremstilling af 3-des-hydroxy-cystatin c eller en modifikation deraf, plasmid og mikroorganisme til udoevelse af fremgangsmaaden og anvendelse af 3-des-oh-cystatin c eller en modifikation deraf til fremstilling af et terapeutisk praeparat
IT8819406V0 (it) Plantare anatomico che permette il massaggio e la respirazione del piede camminando
RU96100904A (ru) Способ лечения миофасциальной люмбалгии у больных с хроническими обструктивными заболеваниями легких
IT1195838B (it) Valvola cardiaca artificiale a due alette

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: SHIONOGI & CO., LTD., OSAKA, JP MATSUO, HISAYUKI,

8366 Restricted maintained after opposition proceedings